Items Tagged ‘basal cell carcinoma’

August 13th, 2015

Food and Drug Administration approves Odomzo for treatment of basal cell carcinoma

By

The U. S. Food and Drug Administration approved Odomzo® (sonidegib, formerly LDE225) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. The approval was based on demonstration of a durable objective response rate […]

View full entry

Tags: basal cell carcinoma, General Skin Cancer, News, odomzo, Skin Cancer


December 3rd, 2014

New Treatment Options Emerging For Advanced Basal Cell Carcinoma

By

Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types of local treatment and are not life threatening. In the most severe cases, the cancer may be very large, may invade structures other than the skin, or may spread to other parts of […]

View full entry

Tags: basal cell carcinoma, everidge, General Skin Cancer, mohs, News, Skin Cancer, vismodegib


June 13th, 2014

Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial

By

An experimental drug sonidegib (LDE225) appears to markedly shrink tumors in patients with advanced basal cell carcinoma according to results recently presented at the 2014 annual meeting of the American Society of Clinical Oncology.1 Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types […]

View full entry

Tags: asco, basal cell cancer, basal cell carcinoma, bcc, General Skin Cancer, LDE225, News, Skin Cancer, sonidegib